About this episode

Dr. Karsten Eastman discusses the significance of peptides in biology and their therapeutic potential, focusing on GLP-1 therapeutics and innovations by Sathera Therapeutics.

In this episode of the Talking Biotech podcast, Dr. Karsten Eastman discusses the significance of peptides in biology and their therapeutic potential. He explains the roles of peptides, particularly GLP-1 therapeutics, and the challenges associated with their stability and bioavailability. The conversation delves into nature's strategies for enhancing peptide stability and how Sathera Therapeutics is innovating in this space to create more effective peptide-based therapies. The discussion also touches on the business model of Sathera and its focus on rare cancers and anti-inflammatory treatments.

Topics covered

• therapeutic peptides
• GLP-1 therapeutics
• peptide stability
• bioavailability
• rare cancers
• anti-inflammatory treatments

Keywords

• Sathera Therapeutics
• peptide-based therapies
• business model

More episodes of Talking Biotech with Dr. Kevin Folta

• Genetic Variation in Vegetative Propagation - Dr. Danelle Seymour · April 1, 2026 · 28 min
• Conditionally Active Therapeutics - Dr. Neela Patel, Dr. Diane Hollenbaugh · February 26, 2026 · 47 min
• A Plasmid-Based Cancer Therapy - Dr. Alexander Schneider · February 16, 2026 · 45 min
• Biotech in Beauty Products - Nicholas Brideau · February 1, 2026 · 1h 13m
• Molecular Biology Giants that Left Us In 2025 · January 23, 2026 · 1h 10m
• TB Throwback- Correcting the Veritasium Episode on Glyphosate · December 26, 2025 · 1h 12m

Explore listener stats, chart rankings, contacts and more on the Talking Biotech with Dr. Kevin Folta podcast page.